Evercore ISI Issues Positive Forecast for CVS Health (NYSE:CVS) Stock Price

CVS Health (NYSE:CVS - Free Report) had its price target boosted by Evercore ISI from $60.00 to $65.00 in a research report sent to investors on Monday morning,Benzinga reports. They currently have an outperform rating on the pharmacy operator's stock.

CVS has been the topic of several other reports. StockNews.com lowered shares of CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday, November 14th. Truist Financial reduced their price target on shares of CVS Health from $67.00 to $60.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price on the stock in a report on Tuesday, December 3rd. TD Cowen raised their price objective on shares of CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, November 25th. Finally, Royal Bank of Canada reduced their price objective on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a report on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $68.12.

CVS Health Stock Up 3.0 %

Shares of CVS traded up $1.65 during trading hours on Monday, hitting $56.20. 11,338,811 shares of the company were exchanged, compared to its average volume of 13,756,655. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company has a market cap of $70.72 billion, a PE ratio of 14.26, a PEG ratio of 0.80 and a beta of 0.59. The firm's 50 day moving average is $51.24 and its 200-day moving average is $56.20. CVS Health has a 52 week low of $43.56 and a 52 week high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.21 earnings per share. On average, equities research analysts forecast that CVS Health will post 5.22 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.73%. The ex-dividend date is Thursday, January 23rd. CVS Health's dividend payout ratio is presently 67.51%.

Institutional Trading of CVS Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Sound Income Strategies LLC grew its stake in CVS Health by 7.2% in the 3rd quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after buying an additional 162 shares during the last quarter. Hexagon Capital Partners LLC increased its holdings in CVS Health by 3.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock valued at $331,000 after buying an additional 178 shares during the period. Bruce G. Allen Investments LLC boosted its position in shares of CVS Health by 13.1% during the 3rd quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator's stock worth $106,000 after acquiring an additional 195 shares in the last quarter. Integrated Advisors Network LLC lifted its stake in CVS Health by 0.7% during the third quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator's stock worth $1,737,000 after purchasing an additional 200 shares during the last quarter. Finally, Widmann Financial Services Inc. boosted its holdings in shares of CVS Health by 1.8% in the 3rd quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator's stock valued at $724,000 after purchasing an additional 200 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.